Summary
The National Institutes of Health (NIH) is soliciting applications for the Clinical and Translational Science Award (CTSA) program under funding opportunity PAR-24-272. This is a UM1 cooperative agreement mechanism where clinical trials are optional. The CTSA program supports institutions in accelerating the translation of laboratory discoveries into treatments for patients, engaging communities in clinical research, and training the next generation of clinical and translational scientists. The opportunity window spans from September 2024 through September 2027, indicating a multi-cycle award opportunity.